162 related articles for article (PubMed ID: 9886170)
1. Multi-drug resistance (MDR1) gene expression in de novo acute leukemia cells: correlations with CD surface markers and treatment outcome.
Jiang EZ; Chang YJ; Lee JW; Lee WK; Kim JS; Sohn SK; Lee KB; Suh JS
J Korean Med Sci; 1998 Dec; 13(6):617-22. PubMed ID: 9886170
[TBL] [Abstract][Full Text] [Related]
2. Relationship between MDR1 gene and surface markers in acute myeloid leukemia.
Zöchbauer S; Schwarzinger I; Strobl H; Lechner K; Pirker R
Anticancer Res; 1997; 17(1B):749-52. PubMed ID: 9066614
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of cell marker analysis in de novo acute myeloid leukemia.
Del Poeta G; Stasi R; Venditti A; Suppo G; Aronica G; Bruno A; Masi M; Tabilio A; Papa G
Leukemia; 1994 Mar; 8(3):388-94. PubMed ID: 7907393
[TBL] [Abstract][Full Text] [Related]
4. Multi-drug resistance (MDR) activity in acute leukemia determined by rhodamine 123 efflux assay.
Lamy T; Drenou B; Grulois I; Fardel O; Jacquelinet C; Goasguen J; Dauriac C; Amiot L; Bernard M; Fauchet R
Leukemia; 1995 Sep; 9(9):1549-55. PubMed ID: 7658724
[TBL] [Abstract][Full Text] [Related]
5. Multidrug resistance-1 (MDR1) expression and functional dye/drug efflux is highly correlated with the t(8;21) chromosomal translocation in pediatric acute myeloid leukemia.
Pearson L; Leith CP; Duncan MH; Chen IM; McConnell T; Trinkaus K; Foucar K; Willman CL
Leukemia; 1996 Aug; 10(8):1274-82. PubMed ID: 8709631
[TBL] [Abstract][Full Text] [Related]
6. Low frequency of activity of P-glycoprotein (P-170) in acute lymphoblastic leukemia compared to acute myeloid leukemia.
Ludescher C; Eisterer W; Hilbe W; Gotwald M; Hofmann J; Zabernigg A; Cianfriglia M; Thaler J
Leukemia; 1995 Feb; 9(2):350-6. PubMed ID: 7869774
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia.
Wuchter C; Leonid K; Ruppert V; Schrappe M; Büchner T; Schoch C; Haferlach T; Harbott J; Ratei R; Dörken B; Ludwig WD
Haematologica; 2000 Jul; 85(7):711-21. PubMed ID: 10897123
[TBL] [Abstract][Full Text] [Related]
8. P-glycoprotein expression and prognostic value in acute myeloid leukemia.
Senent L; Jarque I; Martín G; Sempere A; González-García Y; Gomis F; Pérez-Sirvent M; De La Rubia J; Sanz MA
Haematologica; 1998 Sep; 83(9):783-7. PubMed ID: 9825574
[TBL] [Abstract][Full Text] [Related]
9. Expression of genes related to multiple drug resistance and apoptosis in acute leukemia: response to induction chemotherapy.
Chauhan PS; Bhushan B; Singh LC; Mishra AK; Saluja S; Mittal V; Gupta DK; Kapur S
Exp Mol Pathol; 2012 Feb; 92(1):44-9. PubMed ID: 22037714
[TBL] [Abstract][Full Text] [Related]
10. [The significance of quantification of MDR1 and WT1 gene expression in acute myeloid leukemia].
Xu B; Song XY; Li L; Xu WJ; Tang JH
Zhonghua Nei Ke Za Zhi; 2008 Mar; 47(3):221-4. PubMed ID: 18785507
[TBL] [Abstract][Full Text] [Related]
11. The prognostic significance of the expression and function of multidrug resistance transporter proteins in acute myeloid leukemia: studies of the Southwest Oncology Group Leukemia Research Program.
Willman CL
Semin Hematol; 1997 Oct; 34(4 Suppl 5):25-33. PubMed ID: 9408958
[TBL] [Abstract][Full Text] [Related]
12. Multidrug resistance-associated protein in acute myeloid leukemia: No impact on treatment outcome.
Filipits M; Suchomel RW; Zöchbauer S; Brunner R; Lechner K; Pirker R
Clin Cancer Res; 1997 Aug; 3(8):1419-25. PubMed ID: 9815827
[TBL] [Abstract][Full Text] [Related]
13. Semiquantitative RT-PCR evaluation of the MDR1 gene expression in patients with acute myeloid leukemia.
Trnková Z; Bedrlíková R; Marková J; Michalová K; Stöckbauer P; Schwarz J
Neoplasma; 2007; 54(5):383-90. PubMed ID: 17688368
[TBL] [Abstract][Full Text] [Related]
14. [Expression of MUC1 gene and MDR1 gene in non-M3 subtype acute leukemia and their correlations to clinical treatment efficacy].
Li GW; Wang DN; Lin DJ; Li XD; Lin GZ; He Y; Lin Q; Huang RW
Ai Zheng; 2005 Aug; 24(8):1011-4. PubMed ID: 16086884
[TBL] [Abstract][Full Text] [Related]
15. A new PCR MIMIC strategy to quantify low mdr1 mRNA levels in drug resistant cell lines and AML blast samples.
Illmer T; Schaich M; Oelschlägel U; Nowak R; Renner U; Ziegs B; Subat S; Neubauer A; Ehninger G
Leuk Res; 1999 Jul; 23(7):653-63. PubMed ID: 10400187
[TBL] [Abstract][Full Text] [Related]
16. Expression of multidrug resistance-associated protein (MRP) and multidrug resistance (MDR1) genes in acute myeloid leukemia.
Zhou DC; Zittoun R; Marie JP
Leukemia; 1995 Oct; 9(10):1661-6. PubMed ID: 7564506
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of multidrug resistance gene (MDR1) at relapse in a child with acute lymphoblastic leukemia.
Kourti M; Vavatsi N; Gombakis N; Tzimagiorgis G; Sidi V; Koliouskas D; Athanassiadou F
Pediatr Hematol Oncol; 2006 Sep; 23(6):489-94. PubMed ID: 16849280
[TBL] [Abstract][Full Text] [Related]
18. MDR1 gene expression in acute myeloid leukemia: clinical correlation.
Lin SF; Huang SM; Chen TP; Chang CS; Liu TC; Wang SJ; Liu HW
J Formos Med Assoc; 1995 Mar; 94(3):111-6. PubMed ID: 7613241
[TBL] [Abstract][Full Text] [Related]
19. P-glycoprotein (P-170) expression in acute leukemias.
Abd El-Ghaffar HA; Aladle DA; Farahat SE; Abd El-Hady N
Hematology; 2006 Feb; 11(1):35-41. PubMed ID: 16522547
[TBL] [Abstract][Full Text] [Related]
20. P-glycoprotein expression in patients with acute leukemia-clinical relevance.
Nüssler V; Pelka-Fleischer R; Zwierzina H; Nerl C; Beckert B; Gieseler F; Diem H; Ledderose G; Gullis E; Sauer H; Wilmanns W
Leukemia; 1996 Jul; 10 Suppl 3():S23-S31. PubMed ID: 8656697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]